Step-wise Management of Pediatric Seizure Disorders
The management of pediatric seizure disorders should follow a systematic approach based on seizure classification, etiology identification, and appropriate treatment selection to optimize outcomes related to morbidity, mortality, and quality of life.
Initial Assessment and Classification
- Classify the seizure type: simple partial (without impairment of consciousness), complex partial (with impaired consciousness), or generalized tonic-clonic 1
- Determine if the seizure is febrile (occurring in children 6-60 months with fever) or afebrile 2, 3
- For febrile seizures, further classify as simple (brief <15 minutes, generalized, occurring once in 24 hours) or complex (>15 minutes, focal, or multiple in 24 hours) 2, 3
- Evaluate for signs of status epilepticus, defined as prolonged or repetitive seizures without recovery of consciousness between episodes 4
Diagnostic Evaluation
For First Seizure:
- Obtain detailed history including seizure description, duration, associated symptoms, and risk factors 5
- Perform thorough neurological examination to identify focal deficits 5
- Laboratory studies should be ordered based on clinical circumstances (not routinely) 2:
- Consider electrolytes, glucose, and toxicology screening if clinically indicated 5
- Neuroimaging considerations:
- EEG is recommended as part of the neurodiagnostic evaluation for first unprovoked seizure 2
- Lumbar puncture should be performed if meningitis or encephalitis is suspected 2
Acute Management
For Active Seizure:
Ensure patient safety 6:
- Position patient on side to prevent aspiration
- Remove harmful objects from vicinity
- Do not restrain or place objects in mouth
- Protect head from injury
- Monitor vital signs
For seizures lasting >5 minutes (Status Epilepticus) 4:
- First-line: Benzodiazepines
- Lorazepam 0.05-0.1 mg/kg IV (max 4 mg)
- Diazepam 0.2-0.5 mg/kg IV/rectal (max 10 mg)
- Midazolam 0.2 mg/kg IM/intranasal (max 10 mg)
- Second-line (if seizures continue after 5-10 minutes):
- Fosphenytoin 20 mg PE/kg IV (max 1500 mg PE)
- Valproic acid 20-40 mg/kg IV (max 3000 mg)
- Levetiracetam 20-60 mg/kg IV (max 4500 mg)
- Third-line (refractory status epilepticus):
- Continuous EEG monitoring
- Midazolam, pentobarbital, or propofol infusion
- First-line: Benzodiazepines
For Febrile Seizures:
- Simple febrile seizures typically require only supportive care 2, 3
- Treat underlying fever with antipyretics, though antipyretics have not been shown to prevent recurrence of febrile seizures 2, 3
- Neither continuous nor intermittent anticonvulsant therapy is recommended for children with simple febrile seizures due to potential toxicities outweighing benefits 2, 3
Long-term Management
For Epilepsy:
If first medication fails:
Follow-up monitoring:
For Special Considerations:
- For seizures associated with specific syndromes (e.g., cardio-facio-cutaneous syndrome), follow syndrome-specific protocols 2
- For patients with infantile spasms, consult with cardiologist before steroid management due to risk of cardiomyopathy 2
- For patients receiving CAR T-cell therapy with seizure risk, consider prophylaxis with levetiracetam (10 mg/kg, max 500 mg per dose) every 12 hours for 30 days 2
Surgical Considerations
- Consider epilepsy surgery evaluation for medication-resistant seizures 1
- Refer to specialized epilepsy centers for comprehensive evaluation 1
Follow-up Care
- Regular follow-up with neurologist for ongoing seizure management 2
- Early intervention services for developmental support if indicated 2
- Speech, physical, and occupational therapy as needed based on evaluation 2
Common Pitfalls to Avoid
- Delaying treatment of status epilepticus (treat promptly if seizure lasts >5 minutes) 4
- Routine use of neuroimaging for simple febrile seizures (not recommended) 2, 3
- Prescribing continuous anticonvulsant therapy for simple febrile seizures (risks outweigh benefits) 2, 3
- Polytherapy before optimizing monotherapy (increases side effect risk without proportional benefit) 7, 8
- Inadequate dosing of rescue medications during acute seizures 4